| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 5675 | 2018 |
| Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 EY Klein, TP Van Boeckel, EM Martinez, S Pant, S Gandra, SA Levin, ... Proceedings of the National Academy of Sciences 115 (15), E3463-E3470, 2018 | 2909 | 2018 |
| Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data TP Van Boeckel, S Gandra, A Ashok, Q Caudron, BT Grenfell, SA Levin, ... The Lancet infectious diseases 14 (8), 742-750, 2014 | 2548 | 2014 |
| Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis P Collignon, JJ Beggs, TR Walsh, S Gandra, R Laxminarayan The Lancet Planetary Health 2 (9), e398-e405, 2018 | 622 | 2018 |
| The state of the world's antibiotics 2015 H Gelband, M Miller, Petrie, S Pant, S Gandra, J Levinson, D Barter, ... Wound healing southern africa 8 (2), 30-34, 2015 | 539 | 2015 |
| European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli … M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ... Clinical Microbiology and Infection 28 (4), 521-547, 2022 | 464 | 2022 |
| Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study A Teillant, S Gandra, D Barter, DJ Morgan, R Laxminarayan The Lancet infectious diseases 15 (12), 1429-1437, 2015 | 406 | 2015 |
| Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data EY Klein, M Milkowska-Shibata, KK Tseng, M Sharland, S Gandra, ... The Lancet Infectious Diseases 21 (1), 107-115, 2021 | 325 | 2021 |
| Surveillance for control of antimicrobial resistance E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ... The Lancet Infectious Diseases 18 (3), e99-e106, 2018 | 323 | 2018 |
| Economic burden of antibiotic resistance: how much do we really know? S Gandra, DM Barter, R Laxminarayan Clinical microbiology and infection 20 (10), 973-980, 2014 | 307 | 2014 |
| The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2021 (including the 22nd WHO model list of … World Health Organization World Health Organization, 2021 | 302* | 2021 |
| Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe MR Sharland, C Pulcini, S Harbarth, M Zeng, S Gandra, S Mathur, ... Lancet Infectious Diseases 18 (1), 18-20, 2018 | 297 | 2018 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 263 | 2019 |
| Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach C Pulcini, F Binda, AS Lamkang, A Trett, E Charani, DA Goff, S Harbarth, ... Clinical Microbiology and Infection 25 (1), 20-25, 2019 | 186 | 2019 |
| The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study S Gandra, KK Tseng, A Arora, B Bhowmik, ML Robinson, B Panigrahi, ... Clinical Infectious Diseases 69 (4), 563-570, 2019 | 182 | 2019 |
| Antibiotic prescription practices in primary care in low-and middle-income countries: a systematic review and meta-analysis G Sulis, P Adam, V Nafade, G Gore, B Daniels, A Daftary, J Das, S Gandra, ... PLoS medicine 17 (6), e1003139, 2020 | 177 | 2020 |
| Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014 S Gandra, N Mojica, EY Klein, A Ashok, V Nerurkar, M Kumari, U Ramesh, ... International Journal of Infectious Diseases 50, 75-82, 2016 | 156 | 2016 |
| Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool M Sharland, S Gandra, B Huttner, L Moja, C Pulcini, M Zeng, ... The Lancet Infectious Diseases 19 (12), 1278-1280, 2019 | 148 | 2019 |
| Antimicrobial resistance in low-and middle-income countries: current status and future directions G Sulis, S Sayood, S Gandra Expert review of anti-infective therapy 20 (2), 147-160, 2022 | 143 | 2022 |
| Antimicrobial resistance surveillance in low-and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries S Gandra, G Alvarez-Uria, P Turner, J Joshi, D Limmathurotsakul, ... Clinical Microbiology Reviews 33 (3), 10.1128/cmr. 00048-19, 2020 | 141 | 2020 |
Thomas P Van BoeckelETH Zürich在 env.ethz.ch 的电子邮件经过验证
Thomas P Van BoeckelETH Zürich在 env.ethz.ch 的电子邮件经过验证
Nikolay BraykovGraduate Student, Emory University, Population Biology, Ecology and Evolution Program在 cddep.org 的电子邮件经过验证